Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACALABRUTINIB for B-cell small lymphocytic lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 151 adverse event reports in the FDA FAERS database where ACALABRUTINIB was used for B-cell small lymphocytic lymphoma.

Most Reported Side Effects for ACALABRUTINIB

Side Effect Reports % Deaths Hosp.
Death 1,857 19.2% 1,857 39
Fatigue 536 5.5% 24 91
Headache 534 5.5% 14 83
Product dose omission issue 349 3.6% 4 144
Diarrhoea 320 3.3% 18 85
Fall 289 3.0% 16 149
Malignant neoplasm progression 285 2.9% 48 31
Contusion 270 2.8% 4 42
Dyspnoea 259 2.7% 18 139
Pneumonia 244 2.5% 56 160
Asthenia 243 2.5% 14 108
Pain 225 2.3% 4 64
Atrial fibrillation 217 2.2% 11 70
Arthralgia 209 2.2% 6 33
Nausea 199 2.1% 14 66

Other Indications for ACALABRUTINIB

Chronic lymphocytic leukaemia (4,515) Mantle cell lymphoma (741) Product used for unknown indication (191) B-cell lymphoma (185) Lymphocytic leukaemia (108) Waldenstrom's macroglobulinaemia (94) Chronic lymphocytic leukaemia (in remission) (71) Non-hodgkin's lymphoma (64) Lymphoma (55) Diffuse large b-cell lymphoma (53)

Other Drugs Used for B-cell small lymphocytic lymphoma

IBRUTINIB (1,882) VENETOCLAX (499) RITUXIMAB (248) CYCLOPHOSPHAMIDE (107) LENALIDOMIDE (103) BENDAMUSTINE (94) ZANUBRUTINIB (74) VINCRISTINE (68) IDELALISIB (65) PREDNISONE (60)

Related Pages

ACALABRUTINIB Full Profile All B-cell small lymphocytic lymphoma Drugs ACALABRUTINIB Demographics ACALABRUTINIB Timeline